GH – guardant health, inc. (US:NASDAQ)

News

Guardant Health, Inc. (NASDAQ: GH) had its price target lowered by analysts at Sanford C. Bernstein from $40.00 to $35.00. They now have an "outperform" rating on the stock.
Guardant Health Named to TIME’s List of the Best Inventions of 2024
Table22 Closes $11M Series A to Power Food and Beverage Merchants' E-Commerce Growth [Yahoo! Finance]
Guardant Health to Share Data Supporting Critical Role of Blood-Based Testing in Colorectal Cancer Screening at ACG 2024 [Yahoo! Finance]
Guardant Health to Share Data Supporting Critical Role of Blood-Based Testing in Colorectal Cancer Screening at ACG 2024
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com